首页> 外国专利> ANTI-CANCER DRUG FOR BREAST CANCER, GASTRIC CANCER, AND OVARIAN CANCER

ANTI-CANCER DRUG FOR BREAST CANCER, GASTRIC CANCER, AND OVARIAN CANCER

机译:乳腺癌,胃癌和卵巢癌的抗癌药

摘要

PROBLEM TO BE SOLVED: To provide a drug to treat breast cancer, gastric cancer, and ovarian cancer and a method for application thereof.;SOLUTION: The drug to treat breast cancer, gastric cancer, and ovarian cancer includes: a PPARγ agonist which is administered in combination with an HB-EGF inhibitor; and an HB-EGF inhibitor which is administered in combination with a PPARγ agonist. The method for application of the drug is featured by the combined administration of an HB-EGF inhibitor and a PPARγ agonist in order to inhibit cancer. By using an HB-EGF inhibitor and a PPARγ agonist in combination, an effective treatment of a cancer which is characterized by its high-level expression of HB-EGF, such as breast cancer, can be achieved.;COPYRIGHT: (C)2014,JPO&INPIT
机译:解决的问题:提供一种用于治疗乳腺癌,胃癌和卵巢癌的药物及其应用方法。解决方案:用于治疗乳腺癌,胃癌和卵巢癌的药物包括:一种PPARγ激动剂,它是与HB-EGF抑制剂联合给药; HB-EGF抑制剂与PPARγ激动剂并用。该药物的施用方法的特征在于HB-EGF抑制剂和PPARγ激动剂的联合给药以抑制癌症。通过结合使用HB-EGF抑制剂和PPARγ激动剂,可以有效治疗以HB-EGF高表达为特征的癌症,例如乳腺癌。;版权所有:(C)2014 ,JPO&INPIT

著录项

  • 公开/公告号JP2014009217A

    专利类型

  • 公开/公告日2014-01-20

    原文格式PDF

  • 申请/专利权人 FUKUOKA UNIV;

    申请/专利号JP20120148854

  • 申请日2012-07-02

  • 分类号A61K45/06;A61K31/4439;A61P35/00;A61P43/00;A61K39/395;

  • 国家 JP

  • 入库时间 2022-08-21 16:18:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号